Centro de Investigación Biomédica en Red sobre Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain; Instituto de Investigación Biomédica La Paz (IdiPaz), Madrid, Spain.
Centro de Investigación Biomédica en Red sobre Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain; Fundación de Investigación Biomédica Hospital Universitario de Getafe, Getafe, Spain.
J Nutr Health Aging. 2024 Jun;28(6):100229. doi: 10.1016/j.jnha.2024.100229. Epub 2024 Apr 9.
Supplementation with β-hydroxy β-methyl butyrate (HMB) appears to be effective in preserving muscle in older adults. However, the association between endogenously produced HMB with frailty has not been studied in people with chronic disease.
The purpose of this study is to explore whether an association exists between endogenous HMB levels and frailty status in older adults with type-2 diabetes mellitus (T2DM).
Data were taken from the Toledo Study of Healthy Ageing, a community-dwelling aged (65 years+) cohort. Frailty was assessed at baseline and at 2.99 median years according to the Frailty Phenotype (FP) standardized to our population and the Frailty Trait Scale 12 (FTS12). The associations between HMB levels and frailty were assessed using three nested multivariate logistic regressions and segmented by sex. Glucose, HMB and glucose interaction, age and body composition were used as covariables.
255 participants (mean age 75.3 years, 52.94% men) were included. HMB levels showed an inverse cross-sectional association with frailty, which was modified when the interaction term HMB*glucose was included, remaining significant only for FTS12 [OR (95% CI): 0.436 (0.253, 0.751), p-value 0.003]. The association between HMB endogenous levels and FTS12 appears to be independent of sex, in which the association was maintained after adjusting for the covariates. However, there appears to be threshold points for glucose levels, above which the protective effect of HMB is lost: 145.4 mg/dl adjusted by gender for the whole sample and 149.6 mg/dl and 138.9 mg/dl for men and women, respectively. Endogenous HMB levels were not found to be associated with incident frailty.
Cross-sectional analysis revealed that endogenous HMB levels were inversely associated with frailty as assessed by the FTS12 in older people with T2DM. This association was found to be dependent on circulating fasted glucose levels.
补充 β-羟基-β-甲基丁酸(HMB)似乎可以有效保留老年人的肌肉。然而,在患有慢性病的人群中,内源性 HMB 与虚弱之间的关系尚未得到研究。
本研究旨在探讨 2 型糖尿病(T2DM)老年患者内源性 HMB 水平与虚弱状态之间是否存在关联。
数据来自托莱多健康老龄化研究,这是一个社区居住的老年人(65 岁以上)队列。根据我们人群的衰弱表型(FP)和衰弱特征量表 12(FTS12),在基线和 2.99 中位数年内评估衰弱。使用三个嵌套的多元逻辑回归评估 HMB 水平与虚弱之间的关系,并按性别分段。血糖、HMB 和血糖相互作用、年龄和身体成分用作协变量。
共纳入 255 名参与者(平均年龄 75.3 岁,52.94%为男性)。HMB 水平与虚弱呈负相关,当包含 HMB*血糖交互项时,这种相关性发生了改变,仅对 FTS12 具有统计学意义[比值比(95%置信区间):0.436(0.253,0.751),p 值=0.003]。内源性 HMB 水平与 FTS12 之间的关联似乎独立于性别,在调整协变量后,这种关联仍然存在。然而,血糖水平似乎存在一个阈值点,超过该点,HMB 的保护作用就会丧失:对于整个样本,按性别调整后为 145.4mg/dl,男性和女性分别为 149.6mg/dl 和 138.9mg/dl。内源性 HMB 水平与新发虚弱无关。
横断面分析显示,在患有 T2DM 的老年人中,内源性 HMB 水平与 FTS12 评估的虚弱呈负相关。这种关联依赖于空腹血糖水平。